To make a meaningful impact and meet the needs of citizens, policies and practices in healthcare should be informed by the best evidence. That’s why we’re dedicated to using evidence to shape global health policy in areas in need of transformation.
Our work in this sphere is spearheaded by our Centre for Health Policy, which exists to develop, implement and distribute innovative, evidence-based health policies around the world.
Find out how our Institute is uniting world-leading experts and policy-makers to tackle real-world health problems; promoting learning and support; and generating and sharing evidence-based knowledge on a range of pressing health issues.
Highlights from our health policy work
World Innovation Summit for Health
We’re a partner of the World Innovation Summit for Health, a global community that’s dedicated to capturing and disseminating the best evidence-based ideas and practices in global healthcare.
WISH focuses on some of the most pressing and serious global health challenges facing governments, health systems and populations alike. From mental health to climate change, we work together to rise to the evolving healthcare issues of today, exposing challenges and proposing evidence-based solutions to solve them. To date WISH has published over 40 reports that set out key recommendations to make positive change in these areas of need.
Leading Health Systems Network
Our Leading Health Systems Network (LHSN) joins healthcare leaders and organisations who seek to improve the delivery of healthcare by using resources more effectively and efficiently. This expanding network has grown a global community of like-minded peers who share their ideas, practices and strategies to improve healthcare and overcome challenges in their field.
Alongside producing evidence-based reports aimed at influencing policy, LHSN promotes learning and knowledge sharing through its webinar series. We also offer evidence-based tools to help make healthcare safer, like our hospital checklist for antimicrobial stewardship.
Improving resource allocation for end-of-life care
Research has shown that many patients near the end of life receive high-intensity services without clear evidence of benefits and often at odds with their preferences, with the overwhelming majority of people wishing to remain at home. Yet costly hospital-based care could be avoided if patients were offered high-quality care alternatives outside hospitals.
In partnership with the University of Edinburgh, the University of Lausanne and the Institute for Public Policy Research and public partners, we’re looking at ways to improve the efficiency of health and social care provision at the end of life, and the implications for patients and health systems. We want to find out whether greater efficiency in care resource allocation could enable access to higher-quality and more personalised care for patients.
Our ongoing study is exploring how carers and their loved ones make decisions about end-of-life care, which is necessary to effectively support carers and patients at the end of life to ensure there is high-quality care for all.
Unlocking the benefits of NHS data
The NHS owns long-term health data for the majority of the UK population and this unique asset is poised to be transformative for health, scientific and economic benefit.
Our White Paper, ‘NHS data: Maximising its impact on the health and wealth of the United Kingdom’, offers a framework to guide the proper use of the UK’s health data assets and unlocking their vast potential. Our recommendations include:
- Engaging patients and the public in open and transparent discussions on how their health data is used.
- Establishing clear rules for data access by research organisations and the private sector.
- Recruiting and funding talented data scientists and engineers.
- Establishing government-funded initiatives to improve data quality.
By following these recommendations, policy-makers can harness the potential of the NHS dataset which could drive forward dramatic improvements in health and care, accelerate the development of treatments and technologies, and generate vast income for the UK economy.